Abstract
The transcriptional regulator SnoN has been the subject of growing interest due to its diverse functions in normal and pathological settings. A large body of evidence has established a fundamental role for SnoN as a modulator of signaling and responses by the transforming growth beta (TGFβ) family of cytokines, though how SnoN regulates TGFβ responses remains incompletely understood. In accordance with the critical and complex roles of TGFβ in tumorigenesis and metastasis, SnoN may act as a tumor promoter or suppressor depending on the stage and type of cancer. Beyond its role in cancer, SnoN has also been implicated in the control of axon morphogenesis in postmitotic neurons in the mammalian brain. Remarkably, signaling pathways that control SnoN functions in the divergent cycling cells and postmitotic neurons appear to be conserved. Identification of novel SnoN regulatory and effector mechanisms holds the promise of advances at the interface of cancer biology and neurobiology.
Keywords: SnoN, ING2, Ccd1, TGF-β, Smad, signaling, transcription control, cell cycle, axonal growth, cancer, TGF-b, Homeostasis, Histone deacetylase, Plant homeodomain, Tripartite complex, Oncogene, Tumorigenesis, Barrett's esophagus, Ski, Neurobiology, Metastasis
Current Molecular Medicine
Title: SnoN: Bridging Neurobiology and Cancer Biology
Volume: 10 Issue: 7
Author(s): I. Pot, Y. Ikeuchi, A. Bonni and S. Bonni
Affiliation:
Keywords: SnoN, ING2, Ccd1, TGF-β, Smad, signaling, transcription control, cell cycle, axonal growth, cancer, TGF-b, Homeostasis, Histone deacetylase, Plant homeodomain, Tripartite complex, Oncogene, Tumorigenesis, Barrett's esophagus, Ski, Neurobiology, Metastasis
Abstract: The transcriptional regulator SnoN has been the subject of growing interest due to its diverse functions in normal and pathological settings. A large body of evidence has established a fundamental role for SnoN as a modulator of signaling and responses by the transforming growth beta (TGFβ) family of cytokines, though how SnoN regulates TGFβ responses remains incompletely understood. In accordance with the critical and complex roles of TGFβ in tumorigenesis and metastasis, SnoN may act as a tumor promoter or suppressor depending on the stage and type of cancer. Beyond its role in cancer, SnoN has also been implicated in the control of axon morphogenesis in postmitotic neurons in the mammalian brain. Remarkably, signaling pathways that control SnoN functions in the divergent cycling cells and postmitotic neurons appear to be conserved. Identification of novel SnoN regulatory and effector mechanisms holds the promise of advances at the interface of cancer biology and neurobiology.
Export Options
About this article
Cite this article as:
Pot I., Ikeuchi Y., Bonni A. and Bonni S., SnoN: Bridging Neurobiology and Cancer Biology, Current Molecular Medicine 2010; 10 (7) . https://dx.doi.org/10.2174/156652410792630616
DOI https://dx.doi.org/10.2174/156652410792630616 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy
Current Topics in Medicinal Chemistry The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer
Current Genomics Recent Advances in Anti-Survivin Treatments for Cancer
Current Medicinal Chemistry Survivin: Role in Normal Cells and in Pathological Conditions
Current Cancer Drug Targets Depsipeptide (FK228) as a Novel Histone Deacetylase Inhibitor: Mechanism of Action and Anticancer Activity
Mini-Reviews in Medicinal Chemistry Genistein Down-Regulates miR-223 Expression in Pancreatic Cancer Cells
Current Drug Targets Novel Hybrid Compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutanamide with Antimetastatic and Cytotoxic Action: Synthesis and Anticancer Screening
Anti-Cancer Agents in Medicinal Chemistry LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
Current Enzyme Inhibition Management of the Menopausal Disturbances and Oxidative Stress
Current Pharmaceutical Design Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Chemoprevention of Breast Cancer by Dietary Compounds
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide-Based Anti-Inflammatory and Chemopreventive Therapies: An Experimental Approach
Current Pharmaceutical Design Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer
Current Gene Therapy Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Targeted Therapy in Advanced Gastric Carcinoma: The Future is Beginning
Current Medicinal Chemistry